NOVEL THERAPEUTIC TARGETS FOR AGGRESSIVE PROSTATE CANCER IDENTIFIED THROUGH INDUCED PLURIPOTENT STEM CELL (IPSC) MODELING OF BRCA2MUT PROSTATE TISSUE
$1,124,825FY2024Defense Health AgencyDOD
The University Of Texas Health Science Center At San Antonio